ENG and prostate carcinoma: Endoglin (CD105), a type III transforming growth factor-beta/bone morphogenic protein (TGF-β/BMP) co-receptor, recognized as a marker of proliferating endothelia, is upregulated in several cancers, including prostate cancer [7].